T1	Participants 41 64	RTOG endometrial cancer
T2	Participants 526 600	467 women with type 1 or 2 endometrial cancer and 582 age-matched controls
T3	Participants 1099 1125	type 2 endometrial cancers
T4	Participants 1011 1034	endometrial cancer risk
T5	Participants 1497 1532	risk for type 2 endometrial cancers
